• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT TOTAL PSA; TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT TOTAL PSA; TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER Back to Search Results
Catalog Number 07K70-25
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/23/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 7k70 that has a similar product distributed in the us, list number 6c06.Patient identifier sid: (b)(6).
 
Event Description
The customer reported falsely decreased architect total psa results on four patients.Results provided: (b)(6) 2020: sid: (b)(6) = 13.4443 / 6.655 / 6.95 ng/ml; sid: (b)(6) = 4.09 / 2.279 ng/ml; sid: (b)(6)= 5.432 / 2.717 ng/ml; sid: (b)(6) = 4.963 / 2.713 ng/ml.No impact to patient management was reported.
 
Manufacturer Narrative
A review of complaints for the architect total psa, lot# 11451fn00 assay determined that there are no trends for the product related to patient results.Return testing was not completed as returns were not available.Global data was evaluated and the patient median result for lot 11451fn00 was analyzed and found to be within established baselines and confirms no systemic issues for this lot.A review of the manufacturing documentation did not identify any issues associated with the customer¿s observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect total psa, lot# 11451fn00 assay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key10677985
MDR Text Key211362824
Report Number3008344661-2020-00077
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2020
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/10/2021
Device Catalogue Number07K70-25
Device Lot Number11451FN00
Was Device Available for Evaluation? No
Date Manufacturer Received11/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, ISR06939; ARC I2K PROC MOD, 03M74-01, ISR06939; ARC I2K PROC MOD, 03M74-01, ISR06939
-
-